Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dipivefrine (substance) |
Is a |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclopentolate (substance) |
Is a |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyamfetamine hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 10 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely homatropine hydrobromide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 2% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscine hydrobromide [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscine hydrobromide 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tropicamide 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tropicamide 0.5% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as mydriatic (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.031% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.062% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.25% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 1% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 2% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscine hydrobromide 0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscine hydrobromide 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine eye preparations (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tropicamide 0.5% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tropicamide 1%/mL solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tropicamide 5mg solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ophthalmic hyoscine hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antispasmodic homatropine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydroxyamfetamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tropicamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lachesine chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing homatropine methylbromide and hydrocodone bitartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydroxyamphetamine hydrobromide and tropicamide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lachesine chloride (substance) |
Is a |
False |
Mydriatic |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|